Eisai names new vice president and chief financial officer
5 June 2019 -

Eisai Inc, the US pharmaceutical subsidiary of Eisai Co Ltd, announced yesterday that it has named Patrick Coyle as its new vice president and chief financial officer.

In this role, Coyle will have complete oversight and responsibility for leading Eisai's financial operations in the United States and Canada. He will also serve as a member of the company's Executive Committee.

Coyle is a financial professional who has more than two decades of experience in financial planning and analysis, operations and strategy development from his tenure at several healthcare companies. Before joining Eisai, he served as vice president, Financial Planning and Analysis at INSMED Inc. Previously, he held positions of increasing responsibility in the Finance departments at Novartis, Bayer HealthCare Pharmaceuticals, Sun Chemical and Computer Horizons Corporation.